ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 59 filers reported holding ODONATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $74,000 | -45.2% | 54,472 | +17.5% | 0.00% | – |
| Q3 2021 | $135,000 | -16.1% | 46,344 | +0.3% | 0.00% | – |
| Q2 2021 | $161,000 | -75.0% | 46,228 | -75.4% | 0.00% | – |
| Q1 2021 | $643,000 | -82.7% | 187,876 | -3.0% | 0.00% | -100.0% |
| Q4 2020 | $3,718,000 | +68.8% | 193,662 | +18.0% | 0.00% | – |
| Q3 2020 | $2,203,000 | -68.8% | 164,077 | -1.5% | 0.00% | -100.0% |
| Q2 2020 | $7,056,000 | +89.5% | 166,644 | +23.6% | 0.00% | +100.0% |
| Q1 2020 | $3,724,000 | -26.0% | 134,873 | -13.1% | 0.00% | 0.0% |
| Q4 2019 | $5,035,000 | +21.2% | 155,151 | -2.8% | 0.00% | 0.0% |
| Q3 2019 | $4,156,000 | +5.6% | 159,699 | +48.8% | 0.00% | 0.0% |
| Q2 2019 | $3,937,000 | +71.2% | 107,289 | +3.2% | 0.00% | 0.0% |
| Q1 2019 | $2,299,000 | +78.4% | 103,984 | +13.6% | 0.00% | – |
| Q4 2018 | $1,289,000 | -19.4% | 91,550 | +11.1% | 0.00% | – |
| Q3 2018 | $1,600,000 | -2.7% | 82,425 | +10.6% | 0.00% | – |
| Q2 2018 | $1,645,000 | +10.5% | 74,510 | +6.0% | 0.00% | – |
| Q1 2018 | $1,489,000 | – | 70,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |